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PBaroreflex Sensitivity Predicts
Long-Term Cardiovascular Mortality
After Myocardial Infarction Even in Patients
With Preserved Left Ventricular Function
Gaetano M. De Ferrari, MD,* Antonio Sanzo, MD,* Alessandra Bertoletti, MD,*
Giuseppe Specchia, MD,† Emilio Vanoli, MD,†‡ Peter J. Schwartz, MD*‡§#
Pavia, Monza, and Milan, Italy; and Cape Town, South Africa
Objectives This study sought to assess the long-term predictive power of depressed baroreflex sensitivity (BRS) among post-
myocardial infarction (MI) patients with preserved left ventricular function.
Background Risk stratification after MI is primarily performed by identifying patients with depressed left ventricular ejection
fraction (LVEF) because of their greater mortality. Autonomic markers can help refining risk stratification. De-
pressed BRS (3 ms/mm Hg) correlated with cardiovascular mortality in 1,284 post-MI patients during a 21-
month follow-up in the multicenter ATRAMI (Autonomic Tone and Reflexes After Myocardial Infarction) study, but
had no significant predictive power in patients with LVEF 35% or above age 65 years.
Methods Two hundred forty-four consecutive post-MI patients (age 59  10 years) with LVEF 35% (average 54  8%)
were enrolled. They underwent a complete assessment, including BRS 4 weeks after MI.
Results During a 5-year mean follow-up, 14 (5.7%) patients died of cardiovascular causes. Multivariate analysis identi-
fied BRS (p  0.0001), but not LVEF and age, as predictive of cardiovascular mortality. The relative risk (95%
confidence interval [CI]) for depressed BRS was 11.4 (95% CI 3.3 to 39.0) for the overall population, 19.6 (95%
CI 4.1 to 94.8) for patients 65 years, and 7.2 (95% CI 1.3 to 39.9) for patients above age 65.
Conclusions Even among the large number of low-risk post-MI patients with preserved left ventricular function, depressed
BRS identifies, independently of age, a subgroup at long-term high risk for cardiovascular mortality in which
more aggressive preventive strategies should be considered. (J Am Coll Cardiol 2007;50:2285–90) © 2007 by
the American College of Cardiology Foundation
ublished by Elsevier Inc. doi:10.1016/j.jacc.2007.08.043i
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cespite significant progress, risk stratification after myocar-
ial infarction (MI) is still less than optimal. Most efforts
ave obviously and successfully focused on the high-risk
roups, especially on the patients with depressed left
entricular ejection fraction (LVEF). However, as clev-
rly pointed out by Myerburg and Castellanos (1), such
n approach identifies patients with a high risk for
ardiovascular mortality, which is laudable, but because it
oes so only in a small fraction of the general population
f post-MI patients, the number of absolute deaths
rom the *Department of Cardiology, Fondazione IRCCS Policlinico San Matteo,
avia, Italy; †Department of Cardiology, Policlinico di Monza, Monza, Italy;
Section of Cardiology, Department of Lung, Blood and Heart, University of Pavia,
avia, Italy; §Laboratory of Cardiovascular Genetics, IRCCS Istituto Auxologico,
ilan, Italy; and the #Cardiovascular Genetics Laboratory, Hatter Institute for
ardiovascular Research, Department of Medicine, University of Cape Town, Cape
own, South Africa.s
Manuscript received June 1, 2007; revised manuscript received July 9, 2007,
ccepted August 6, 2007.nvolved is actually small. To make an impact on overall
ardiovascular mortality it would be necessary to identify
ndividuals at increased risk among the much larger
opulation at relatively low risk. This is what we at-
empted to do in the present study.
See page 2291
Aside from depressed LVEF, several additional risk
redictors have been proposed and validated, and among
hem significant prognostic value had been provided by
utonomic markers (2), including baroreflex sensitivity
BRS) (2,3), heart rate variability (2,4), and heart rate
urbulence (5). The background and rationale for these
tudies lies in the tight relationship between autonomic
mbalance (i.e., increased sympathetic activity and/or de-
reased vagal activity) and life-threatening arrhythmias
hown by a wealth of experimental (6–8) and clinical
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the largest was the ATRAMI
(Autonomic Tone and Reflexes
After Myocardial Infarction)
study (9,10), which showed that
depressed BRS was associated
with increased cardiac mortality
over a 21-month follow-up period.
However, the predictive value of
depressed BRS did not reach sta-
tistical significance among patients
over 65 years of age and among
patients with preserved left ven-
tricular (LV) function (LVEF
35%). This latter finding left a
question about the potential of
depressed BRS to help identify
individuals at high risk within a
arge low-risk population.
Accordingly, the present prospective study was designed
o assess, during long-term follow-up, the predictive role of
epressed BRS in the largest group of post-MI patients,
amely those with preserved LV function who are at low
isk of cardiac death.
ethods
his was a single-center prospective study enrolling patients
ischarged from the hospital in the years 1999 to 2000 after
n acute MI with preserved LV function (LVEF 35%).
he diagnosis of acute MI was based on clinical course,
erum creatinine kinase levels, and electrocardiogram
ECG) findings of ST-segment elevation.
All patients with an ST-segment elevation MI were
cheduled for a follow-up outpatient visit at our post-MI
linic 30 to 40 days after MI. Only patients who could not
ome for the regular visits (usually because of logistical
easons such as distance from the hospital) or who under-
ent a surgical revascularization followed by a rehabilitation
hase in specialized centers did not follow this schedule
these cases together represent 10% of the population).
ll consecutive patients presenting at the post-infarction
linic after an ST-segment elevation MI in the years 1999 to
000 (n  468) were screened for eligibility in the study.
xclusion criteria were: LVEF 35%, advanced valvular
eart disease, unstable angina or congestive heart failure,
trial fibrillation or abnormal sinus node function, arterial
lood pressure above 160/90 mm Hg at the time of BRS
etermination and any disease limiting survival, or refusal to
ive informed consent to the study. During the outpatient
isit, the enrolled subjects underwent measurement of LV
unction by means of echocardiography, followed by auto-
omic assessment.
utonomic assessment. The protocol was the same as
sed in previous studies (13–15). Patients were studied
Abbreviations
and Acronyms
ACE  angiotensin-
converting enzyme
BRS  baroreflex
sensitivity
CI  confidence interval
ECG  electrocardiogram
IQR  interquartile range
LV  left ventricular
LVEF  left ventricular
ejection fraction
MI  myocardial infarction
SDANN  standard
deviation of the average
RR intervalhile supine at rest in a quiet temperature-controlled room, th after a light meal, and they were asked to relax and to
void talking and sleeping. The ECG recording was started
fter 10 to 15 min of acclimatization. The analog ECG
ignal was digitized at 500 Hz, and the QRS complex was
ecognized by cross-correlation with a template chosen by
he investigator. A 10-min recording was performed and
sed to derive the standard deviation of the average RR
nterval (SDANN).
For the BRS assessment, phenylephrine (2 to 4 g/kg)
as given intravenously by at least 3 bolus injections,
eparated by 10-min intervals, to increase systolic
rterial pressure by 15 to 40 mm Hg (in most cases 15 to
0 mm Hg) (3,16). Beat-to-beat systolic arterial pressure
as measured noninvasively by means of infrared pleth-
smography with a finger cuff (Finapres 2300, Ohmeda,
inapres Medical Systems, Amsterdam, the Nether-
ands). Several thousand tests have been performed by our
roup with this protocol producing only rare, transient,
nd minor side effects (such as horripilation or mild
eadache). No serious or significant side effect has ever
ccurred. Custom-made software was used for detection
f QRS and blood pressure signal and for calculating
RS as the slope of the regression line correlating systolic
lood pressure and RR interval changes after phenyleph-
ine injection. Baroreflex sensitivity was considered de-
ressed, similar to previous studies (10), if it was 3
s/mm Hg.
tatistical analysis. Continuous variables are presented as
ean  standard deviation or as median and interquartile
ange (IQR) for non-normal variables. Comparisons were
ade by Student t test or Mann-Whitney U test, as
ppropriate. Categorical variables were described as fre-
uencies and compared by the Fisher exact test (2-tailed).
he BRS was dichotomized using the pre-specified and
alidated (10) cutoff value of 3 ms/mm Hg. To compare
ts predictive value with that of LVEF, the latter was
ichotomized using 45% as the cutoff value in some
nalyses. The pre-specified primary end point of the study
as cardiovascular mortality; the secondary end point was
ll-cause mortality.
The main analyses were performed for the entire popu-
ation as well as for the 2 pre-specified age subgroups (65
nd 65 years). Kaplan-Meier estimates of event-free
urvival were plotted and compared by the log-rank test.
he Cox proportional hazards model was used to evaluate
he predictive value of BRS, LVEF (both continuous and
ichotomized), age, and site of infarction on cardiovascular
ortality. Further analyses were performed adding, as an
dditional factor to the model that included age, BRS, and
VEF, one of the following variables: gender, SDANN,
eta-blocker use, angiotensin-converting enzyme (ACE)
nhibitor use, and diuretic use.
Statistica 6.1 (StatSoft, Tulsa, Oklahoma) was used for
he analysis. A value of p  0.05 was considered significant.
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tudy population characteristics. The study enrolled 244
atients who met the inclusion/exclusion criteria and signed
he informed consent (mean age 59  10 years) (Table 1).
s expected from the inclusion criteria, the average LVEF
as normal (54  8%). The median BRS was 6.9 ms/mm
g in the entire population. It was higher among patients
ges 65 years (median 7.6 ms/mm Hg, IQR 5.0 to 10.9
s/mm Hg) compared with patients65 years old (median
.3 ms/mm Hg, IQR 2.8 to 7.7 ms/mm Hg, p  0.0001).
moderate negative correlation was found between BRS
nd age (r  0.39, p  0.0001). Patients with depressed
RS (i.e., 3 ms/mm Hg) were 35 of 244 (14%). This
ccurred more frequently among patients 65 years (21 of
6, 28%) compared with younger patients (14 of 168, 8%,
 0.0001). An LVEF 45% was present in 11% (28 of
44) of the overall population, and tended to be more
requent among the older than the younger patients (15 of
6, 20% vs. 13 of 168, 8%, p  0.06). Ninety-eight percent
f patients were treated with aspirin, 84% with beta-
lockers, 62% with ACE inhibitors, and 19% with diuretics.
eta-blockers were given to 91% of patients with depressed
RS and 83% of patients with preserved BRS.
ollow-up and survival analysis. The average follow-up
as 61 19 months. During this period, 19 patients (7.8%)
ied. The primary end point of the study, cardiovascular
eath, occurred in 14 patients (5.7%). Cardiovascular death
ccurred in 4.2% of men and 11% of women (p  0.09); in
.1% of reperfused versus 4.6% of nonreperfused patients
p 0.65); in 4.6% versus 12.1% of patients treated and not
reated with beta-blockers, respectively (p  0.11); in 7.8%
ersus 3.2% of patients treated and not treated with ACE
nhibitors, respectively (p 0.24); and in 16.1% versus 3.7%
f patients treated and not treated with diuretics, respec-
ively (p  0.02).
The patients who died of cardiovascular causes, when
ompared with survivors, had similar LVEF (52  9% vs.
4  8%, p  0.26) and prevalence of reperfusion (78% vs.
haracteristics of the Enrolled Patients
Table 1 Characteristics of the Enrolled Patients
Patients 244
Men 190 (78%)
Age (yrs) 59  10
Infarct site
Anterior 107 (44%)
Nonanterior 127 (56%)
Reperfusion therapy
Primary PCI 91 (37%)
Pharmacological 89 (37%)
None 64 (26%)
LVEF (%) 54 8
BRS (ms/mm Hg)
Mean  SD 8.2 6.3
Median 6.9a
RS baroreflex sensitivity; LVEF left ventricular ejection fraction; PCI percutaneous coronary
ntervention.2%), but tended to be older (64  8 years vs. 58  11
ears, p  0.06). They also had a slightly but significantly
ower SDANN: median 18.5 ms (IQR 12.4 to 37.1 ms)
ersus 30 ms (IQR 22.3 to 40.3 ms), p  0.03. Compared
ith survivors, patients with a primary end point had a
arkedly lower BRS: median 2.6 ms/mm Hg (IQR 1.6 to
.2 ms/mm Hg) versus 7.0 ms/mm Hg (IQR 4.5 to 10.3
s/mm Hg), p  0.0002. Cardiovascular mortality was
ignificantly and strikingly greater among patients with
epressed BRS, as shown in Figure 1, which illustrates the
rogressive divergence of the 2 survival curves. Cardiovas-
ular mortality for patients with depressed BRS was much
reater in the overall population and in the 2 different age
ubgroups (Fig. 2). On the other hand, no difference in
ardiovascular mortality was found by comparing patients
ith LVEF between 35% and 45% (n  28) versus 45%
n  216). Multivariate analysis of predictors of cardiovas-
ular mortality was performed entering in the model age,
ender, site of infarction, LVEF (both continuous and
ichotomic), and BRS. This analysis identified depressed
RS as the sole statistically significant predictor (p 
.0001). The relative risk and 95% confidence interval (CI)
ssociated with depressed BRS was 11.4 (95% CI 3.3 to
9.0, p  0.0001) for the overall population, 19.6 (95% CI
.1 to 94.8, p  0.0002) for patients 65 years old, and 7.2
95% CI 1.3 to 39.9, p  0.02) for patients 65 years old.
All-cause mortality was also significantly higher among
atients with depressed BRS, as shown in Figure 3. Multi-
ariate analysis of predictors of all-cause mortality identified
epressed BRS as the sole statistically significant predictor
ith a relative risk of 4.9 (95% CI 1.8 to 13.4, p  0.002).
iscussion
he present study provides the first evidence that an
utonomic marker, depressed BRS, is a powerful predictor
f long-term cardiovascular mortality after MI even among
he large population of patients with well-preserved LV
unction generally considered to be all at low risk. This
redictive power was not limited to specific age groups
ecause it was also present among older patients. These data
arkedly extend our previous findings (10) and may pave
he way toward targeted aggressive preventive strategies for
elected patients within the vast population generally
hought to be at low risk.
ost-MI prognosis and the role of depressed BRS. The
urrent approach for primary prophylaxis after MI focuses
n patients with depressed LV function (17). However, the
se of a single risk predictor, especially one burdened by a
arge measurement error, as occurs with LVEF (18), has 2
ignificant drawbacks (19). On the one hand, not all
atients with depressed LVEF are truly at high risk (19), as
uggested also by the relatively low mortality of those with
ell-preserved BRS (10). On the other hand, a significant
inority of patients with an LVEF above 30% to 35% may bet high risk and are not correctly identified (19). Because the
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Baroreflexes and Long-Term Cardiovascular Mortality December 11, 2007:2285–90otal number of patients with preserved LV function after MI
reatly exceeds that of patients with depressed LV function,
his approach actually fails to identify the majority of patients
t risk for cardiovascular mortality in the follow-up.
This study was indeed designed to assess whether a
epressed BRS could be of value in identifying the subgroup
t relatively higher long-term risk among post-MI patients
eemed to be at low risk because of preserved LV function.
The prognostic value of depressed BRS had been sug-
ested first in an established animal model of sudden cardiac
eath (6,20) and subsequently in 2 relatively small clinical
tudies (9,21). It was then conclusively shown by the
TRAMI study (10), which showed that depressed BRS
3 ms/mm Hg) significantly predicts cardiac mortality.
owever, during the 21-month average follow-up, despite a
rend toward possible differences, BRS failed to reveal a
ifferent mortality risk among patients with either age 65
ears or LVEF 35%. For this reason we decided to focus
ur attention on patients with preserved LV function, who
n the current era of aggressive reperfusion constitute the
ast majority of the population, and to study them over a
ong follow-up period. We found depressed BRS to be an
xtremely powerful predictor of cardiovascular mortality
ver the long term in this low-risk population of patients.
wo additional clinical features were found to be unequally
istributed among patients with and patients without cardio-
ascular mortality. They were the SDANN (a time-domain
easure of heart rate variability, largely an expression of vagal
one) that was lower among patients with cardiovascular death,
nd the use of diuretics that was more frequent among patients
ith cardiovascular death. Neither of these variables had a
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1.0
p < 0.0001
244 236 228 223 197 151 74Total
209 204 198 195 173 134 68BRS
35 32 30 28 24 17 6
1 2 3 4 5 60
Follow-up (years)
C
u
m
u
la
ti
ve
su
rv
iv
al
Figure 1 Survival Curve for Freedom
From Cardiovascular Death
Kaplan-Meier event-free survival curves relative to the primary end point (cardio-
vascular death) in the 2 groups of patients. Broken red line  patients with
depressed baroreflex sensitivity (BRS); solid green line  patients with pre-
served BRS.redictive power at multivariate analysis.Cardiovascular mortality among patients with depressed
RS was 26%, compared with 2.4% in the remaining
opulation, with a relative risk of 11.4. This predictive role
as present also in patients 65 years of age who had a
elative risk of 7.2. Thus, depressed BRS correctly identifies
atients at high risk for cardiovascular events over the long
erm, independently of age, gender, site of infarction, and
V function, within patients with normal or mildly de-
ressed ejection fraction. The statistical power of the multi-
ariate and of the subgroup analyses was somewhat reduced
y the relatively small number of cardiovascular deaths.
Importantly, the survival curves of patients with normal
r depressed BRS continue to diverge over the long term.
his points to the fact that BRS provides information on an
ndividual characteristic likely to maintain its predictive
alue over time. This observation raises the intriguing
ossibility that the level of BRS may represent a genetic
rait, a sort of autonomic fingerprint containing information
n the likelihood of developing life-threatening events
specially during an acute ischemic episode. This autonomic
ngerprint would provide information valid even over ex-
ended periods of time. Two independent sets of data
lready support this concept. Increases in BRS induced
y exercise training are associated with a significant
rotection from cardiovascular mortality over a period of
0 years (22). Heart rate changes during an exercise stress
est in healthy subjects carry information predictive for
he risk of sudden cardiac death over 2 decades (23).
BRS ≥ 3 ms/mmHg
5%
10%
15%
20%
25%
30%
All Patients Patients ≤
n=
BRS < 3 ms/mmHg
35     209            14     154           21       55
Figure 2 Occurrence of Cardiovascular
Death on the Basis of Age and BRS
Cardiovascular mortality on the basis of baroreflex sensitivity (BRS) in the dif-
ferent age groups. The number of patients in each group is listed below the
bar. Red bars  patients with depressed BRS; green bars  patients with pre-
served BRS.
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December 11, 2007:2285–90 Baroreflexes and Long-Term Cardiovascular Mortalityaken together, these studies and the present results
trongly suggest, as previously proposed (24), that the
ndividual autonomic make-up is at least in part geneti-
ally controlled and that, accordingly, the analysis of
eaningful autonomic parameters may be of prognostic
alue also for events distant in time.
epressed BRS and increased cardiovascular mortality.
ultiple mechanisms contribute to the explanation of the
trong association between low BRS values and increased
ortality.
A post-MI depressed BRS suggests that sympathetic
ctivity is increased (either in absolute or in relative terms)
nd/or unopposed by adequate vagal activity, thus identify-
ng a shift of the autonomic balance toward a sympathetic
redominance (3). The deleterious role of increased sympa-
hetic activity in triggering cardiovascular mortality by a
ariety of mechanisms is well recognized (25). Also, abun-
ant data support the protective role of vagal activity against
ife-threatening ventricular arrhythmias, particularly in the
etting of myocardial ischemia (26,27). Indeed, animal
xperiments indicate that the presence of adequate vagal
eflexes may represent the main mechanism preventing
entricular fibrillation during acute myocardial ischemia
28). Among post-MI patients, depressed BRS is also
orrelated with a greater probability of ventricular tachycar-
ia and with a higher risk of hemodynamic deterioration
uring the tachycardia (15).
Depressed BRS post-MI may be a marker of increased
eurohormonal activation, a condition favoring LV remod-
ling and the development and progression of heart failure
29). This concept has played a role in the ongoing
ssessment of the effects of vagal stimulation in patients
ith heart failure (30). Finally, unopposed sympathetic
Follow-up (years)
244 236 228 223 197 151 74Total
209 204 198 195 173 134 68BRS
35 32 30 28 24 17 6
1 2 3 4 5 6
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p = 0.0007
Figure 3 Survival Curve for Freedom From All-Cause Mortality
Kaplan-Meier survival curves in the 2 groups of patients for total mortality.
Broken red line  patients with depressed baroreflex sensitivity (BRS); solid
green line  patients with preserved BRS.ctivity may also facilitate myocardial ischemia by increasinghear stress and by increasing the propensity of platelets to
ggregate (25).
otential implications. The most relevant potential impli-
ation of these findings is represented by the novel oppor-
unity to implement preventive measures destined to affect
ruly large numbers of individuals. Indeed, they indicate that
t is possible to identify, even among low-risk post-MI
atients with preserved LV function and with an overall
ardiovascular mortality just above 1% per year, a group with
-year mortality of 25%. These persons deserve a targeted
nd more aggressive approach.
Beta-blockers with doses adequate to counter the early
orning surge in sympathetic activity, ACE inhibitors, and
ual antiplatelet treatment (31) should all be considered for
he pharmacological approach. Exercise training may have a
pecial role for post-MI patients with depressed BRS.
xercise-induced increases in BRS post-MI are associated
ith reduced risk for sudden death both experimentally (32)
nd clinically (22), provided that it produces an adequate
hift of the autonomic balance toward an increase in vagal
ctivity. For patients with persistence of depressed BRS
espite exercise training, further stratification of arrhythmic
isk, including microvolt T-wave alternans (33), may be
arranted.
onclusions
mong post-MI patients with preserved LV function,
epresenting the large group at very low risk, those with
epressed BRS have a high incidence of cardiovascular
ortality during long-term follow-up irrespective of age
nd of site of MI. Their risk for cardiovascular death is more
han 11 times higher than that of patients with preserved
RS. For their protection, a more aggressive preventive
trategy should be considered.
eprint requests and correspondence: Dr. Gaetano M. De
errari, Department of Cardiology, Fondazione IRCCS Poli-
linico San Matteo, Viale Golgi, 19, 27100 Pavia, Italy. E-mail:
.deferrari@smatteo.pv.it.
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